Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Abstract Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option. Methods In this open-label, single-center, case–control...
Main Authors: | Nik Krajnc, Bianca Itariu, Stefan Macher, Wolfgang Marik, Jürgen Harreiter, Martin Michl, Klaus Novak, Christian Wöber, Berthold Pemp, Gabriel Bsteh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-07-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10194-023-01631-z |
Similar Items
-
MRI features of idiopathic intracranial hypertension are not prognostic of visual and headache outcome
by: Gabriel Bsteh, et al.
Published: (2023-07-01) -
Migraine headache in patients with idiopathic intracranial hypertension
by: Farzad Sina, et al.
Published: (2017-10-01) -
Spontaneous Intracranial Hypotension without Orthostatic Headache
by: Tülay Kansu, et al.
Published: (2009-03-01) -
A Rare Cause of Headache and Increased Intracranial Pressure: Primary Leptomeningeal Melanomatosis
by: Aslan Tekataş, et al.
Published: (2014-12-01) -
Spontaneous intracranial hypotension following spinal anesthesia initially misdiagnosed as postdural puncture headache
by: Hyun-Seong Lee, et al.
Published: (2022-01-01)